Literature DB >> 26833406

Exploiting drug repositioning and the brain microenvironment to treat brain metastases.

Robert S Kerbel1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26833406      PMCID： PMC4799688          DOI： 10.1093/neuonc/nov327

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  16 in total

Review 1.  Endothelin B receptor, a new target in cancer immune therapy.

Authors:  Lana E Kandalaft; Andrea Facciabene; Ron J Buckanovich; George Coukos
Journal:  Clin Cancer Res       Date:  2009-06-30       Impact factor: 12.531

Review 2.  Brain metastases.

Authors:  Andrew D Norden; Patrick Y Wen; Santosh Kesari
Journal:  Curr Opin Neurol       Date:  2005-12       Impact factor: 5.710

3.  The brain microenvironment and cancer metastasis.

Authors:  Isaiah J Fidler; Krishnakumar Balasubramanian; Qingtang Lin; Seung Wook Kim; Sun-Jin Kim
Journal:  Mol Cells       Date:  2010-08-19       Impact factor: 5.034

4.  Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy.

Authors:  Sun-Jin Kim; Jang-Seong Kim; Eun Sung Park; Ju-Seog Lee; Qingtang Lin; Robert R Langley; Marva Maya; Junqin He; Seung-Wook Kim; Zhang Weihua; Krishnakumar Balasubramanian; Dominic Fan; Gordon B Mills; Mien-Chie Hung; Isaiah J Fidler
Journal:  Neoplasia       Date:  2011-03       Impact factor: 5.715

5.  Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy.

Authors:  Ronald J Buckanovich; Andrea Facciabene; Sarah Kim; Fabian Benencia; Dimitra Sasaroli; Klara Balint; Dionysios Katsaros; Anne O'Brien-Jenkins; Phyllis A Gimotty; George Coukos
Journal:  Nat Med       Date:  2008-01-06       Impact factor: 53.440

6.  Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer.

Authors:  Joel B Nelson; William Love; Joseph L Chin; Fred Saad; Claude C Schulman; Darryl J Sleep; Jiang Qian; Joyce Steinberg; Michael Carducci
Journal:  Cancer       Date:  2008-11-01       Impact factor: 6.860

7.  Treatment of experimental human breast cancer and lung cancer brain metastases in mice by macitentan, a dual antagonist of endothelin receptors, combined with paclitaxel.

Authors:  Ho Jeong Lee; Masaki Hanibuchi; Sun-Jin Kim; Hyunkyung Yu; Mark Seungwook Kim; Junqin He; Robert R Langley; François Lehembre; Urs Regenass; Isaiah J Fidler
Journal:  Neuro Oncol       Date:  2016-04       Impact factor: 12.300

Review 8.  Brain metastases: the HER2 paradigm.

Authors:  Nancy U Lin; Eric P Winer
Journal:  Clin Cancer Res       Date:  2007-03-15       Impact factor: 12.531

Review 9.  The endothelin axis: emerging role in cancer.

Authors:  Joel Nelson; Anna Bagnato; Bruno Battistini; Perry Nisen
Journal:  Nat Rev Cancer       Date:  2003-02       Impact factor: 60.716

Review 10.  Endothelin receptor antagonists in cancer therapy.

Authors:  Mihailo Lalich; Douglas G McNeel; George Wilding; Glenn Liu
Journal:  Cancer Invest       Date:  2007-12       Impact factor: 2.176
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.